Analysis of an additional dataset for BCP-ALL patients (GSE10792) confirmed widespread expression of IRX1 and restricted activities of IRX3 to subtypes ETV6 and KMT2A, and of MEIS1 to subtype KMT2A (Figure S3). The gene discussed is IRX3; the disease is acute lymphoblastic leukemia.